Inclusion Criteria:  Diagnosed patients with spontaneous cerebral hemorrhage in the basal ganglia (in line with the diagnostic criteria of the American Adult Spontaneous Cerebral Hemorrhage Treatment Guidelines (2015)). Head CT showed; hematoma volume ≥ 30ml, intraventricular hemorrhage is not counted as hemorrhage volume. Time from onset to hospital admission ≤8h. The age of the patient is 15-75 years old. Glasgow Coma Score (GCS)> 5 points. The patient/family knows and signs the informed consent form. Have a clear history of hypertension in the past.  Exclusion Criteria:  Bleeding caused by aneurysm, vascular malformation or tumor stroke. Combined with a history of head injury or trauma. There is more blood in the skull. Past mental disorders or neurological dysfunction. A history of procoagulant dysfunction or anticoagulant drugs. Patients with complications such as liver and kidney dysfunction. Those with poor compliance. Pregnant patients. With massive hemorrhage of the ventricle (the area of the hematoma in the CT side is larger than 1/2 of the transverse section), hemorrhage in the third and fourth ventricles with enlarged ventricles. With late-stage cerebral herniation (bilateral dilated pupils, central respiratory and circulatory failure). Severe cardiovascular and cerebrovascular diseases: such as myocardial infarction, cerebral infarction, coronary heart disease, myocarditis, malignant arrhythmia, etc. Participate in other clinical research 3 months before enrollment. The doctor in charge believes that the study plan cannot be followed. Those who are or plan to become pregnant or breastfeeding. Those who are known to be allergic to test drugs or related products.